Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2021-02-11 5:27 pm Purchase | 13G | CYTOMX THERAPEUTICS INC CTMX | BIOTECHNOLOGY VALUE FUND L P | 5,576,471 12.1% | 950,060 (+20.54%) | View |
| 2021-02-10 10:46 am Purchase | 13G | CYTOMX THERAPEUTICS INC CTMX | VANGUARD GROUP INC | 2,934,424 6.35% | 244,820 (+9.10%) | View |
| 2021-02-02 3:13 pm Sale | 13G | CYTOMX THERAPEUTICS INC CTMX | VICTORY CAPITAL MANAGEMENT INC | 2,728,037 7.11% | -85,414 (-3.04%) | View |
| 2021-01-29 4:30 pm Purchase | 13G | CYTOMX THERAPEUTICS INC CTMX | RA CAPITAL MANAGEMENT L.P. | 3,500,000 5.8% | 3,500,000 (New Position) | View |
| 2021-01-29 09:56 am Sale | 13G | CYTOMX THERAPEUTICS INC CTMX | BlackRock Inc. BLK | 3,805,179 8.2% | -210,869 (-5.25%) | View |
| 2021-01-26 5:20 pm Purchase | 13G | CYTOMX THERAPEUTICS INC CTMX | Point72 Asset Management L.P. | 5,523,906 9.1% | 5,523,906 (New Position) | View |
| 2020-11-10 4:58 pm Purchase | 13G | CYTOMX THERAPEUTICS INC CTMX | BIOTECHNOLOGY VALUE FUND L P | 4,626,411 10% | 1,437,463 (+45.08%) | View |
| 2020-03-06 5:29 pm Purchase | 13G | CYTOMX THERAPEUTICS INC CTMX | BIOTECHNOLOGY VALUE FUND L P | 3,188,948 7% | 2,064,465 (+183.59%) | View |
| 2020-02-14 4:18 pm Purchase | 13G | CYTOMX THERAPEUTICS INC CTMX | PERCEPTIVE ADVISORS LLC | 3,253,923 7.2% | 262,208 (+8.76%) | View |
| 2020-02-14 1:30 pm Sale | 13G | CYTOMX THERAPEUTICS INC CTMX | PRICE T ROWE ASSOCIATES INC | 686,188 1.5% | -3,405,338 (-83.23%) | View |
| 2020-02-11 4:40 pm Purchase | 13G | CYTOMX THERAPEUTICS INC CTMX | VANGUARD GROUP INC | 2,689,604 5.91% | 2,689,604 (New Position) | View |
| 2020-02-05 11:45 am Purchase | 13G | CYTOMX THERAPEUTICS INC CTMX | BlackRock Inc. BLK | 4,016,048 8.8% | 155,120 (+4.02%) | View |
| 2020-01-31 10:23 am Purchase | 13G | CYTOMX THERAPEUTICS INC CTMX | VICTORY CAPITAL MANAGEMENT INC | 2,813,451 6.19% | 2,813,451 (New Position) | View |
| 2020-01-27 2:03 pm Sale | 13G | CYTOMX THERAPEUTICS INC CTMX | WELLINGTON MANAGEMENT GROUP LLP | 130,332 0.29% | -2,547,326 (-95.13%) | View |